Magnus Nydén

Magnus Nydén leads the Digital Science, Business Development and Science & Innovation teams within PT&D. Additionally, he leads a program aimed at creating a holistic digital twin of AstraZeneca’s Development process, employing various AI methods, including Generative AI. This initiative seeks to optimize the development process, reduce costs, lower the carbon footprint, and enhance productivity, ultimately improving the accessibility and affordability of medicines for our patients. With a career spanning both academia and industry, Magnus brings expertise that allows him to act at the interfaces between chemistry, physics, biology, material science, spectroscopy and applied mathematics, including artificial intelligence. Magnus holds MSc and PhD in Physical Chemistry and Material Science from Lund University, specializing in Nuclear Magnetic Resonance. Magnus’s professional journey is complemented by his passion for the ocean and racket sports.